slotkoers
Palestine Exchange
00:00:00 25-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3,81
USD
|
0,00%
|
|
-0,52%
|
+0,26%
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
58,68
|
58,32
|
50,4
|
49,86
|
50,94
|
59,04
|
Bedrijfswaarde
1 |
56,64
|
57,5
|
53,52
|
51,69
|
48,08
|
53,44
|
K/w-verhouding
|
9,57
x
|
9,52
x
|
9,42
x
|
13,4
x
|
7,72
x
|
8,23
x
|
Dividendrendement
|
3,07%
|
3,09%
|
3,57%
|
2,89%
|
4,24%
|
4,57%
|
Marktkapitalisatie/omzet
|
1,97
x
|
1,89
x
|
1,48
x
|
1,37
x
|
1,1
x
|
1,28
x
|
Bedrijfswaarde/omzet
|
1,9
x
|
1,87
x
|
1,57
x
|
1,42
x
|
1,04
x
|
1,16
x
|
Bedrijfswaarde/EBITDA
|
7,98
x
|
7,93
x
|
7,79
x
|
8,69
x
|
4,83
x
|
5,07
x
|
Bedrijfswaarde/FCF
|
-235
x
|
150
x
|
-24
x
|
-43,7
x
|
19,4
x
|
4,25
x
|
FCF Yield
|
-0,43%
|
0,67%
|
-4,17%
|
-2,29%
|
5,16%
|
23,5%
|
Price to Book
|
1,21
x
|
1,2
x
|
0,96
x
|
0,84
x
|
0,77
x
|
0,92
x
|
Aantal aandelen (in duizenden)
|
18.000
|
18.000
|
18.000
|
18.000
|
18.000
|
18.000
|
Referentieprijs
2 |
3,260
|
3,240
|
2,800
|
2,770
|
2,830
|
3,280
|
Datum van publicatie
|
31/03/18
|
1/04/19
|
7/05/20
|
10/05/21
|
31/03/22
|
1/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
29,79
|
30,8
|
34,09
|
36,4
|
46,23
|
46,14
|
EBITDA
1 |
7,1
|
7,246
|
6,873
|
5,946
|
9,946
|
10,53
|
Bedrijfsresultaat (EBIT)
1 |
5,665
|
5,664
|
5,194
|
4,012
|
7,985
|
8,808
|
Operationele Marge
|
19,02%
|
18,39%
|
15,24%
|
11,02%
|
17,27%
|
19,09%
|
Resultaat voor belastingen (EBT)
1 |
6,266
|
6,115
|
5,027
|
3,741
|
7,622
|
9,03
|
Nettowinst (verlies)
1 |
6,131
|
6,125
|
5,351
|
3,725
|
6,598
|
7,174
|
Nettomarge
|
20,58%
|
19,88%
|
15,7%
|
10,23%
|
14,27%
|
15,55%
|
WPA
2 |
0,3406
|
0,3403
|
0,2973
|
0,2070
|
0,3665
|
0,3985
|
Free Cash Flow
1 |
-0,2415
|
0,3841
|
-2,233
|
-1,182
|
2,482
|
12,57
|
FCF-marge
|
-0,81%
|
1,25%
|
-6,55%
|
-3,25%
|
5,37%
|
27,25%
|
Kasstroomconversie (ebitda)
|
-
|
5,3%
|
-
|
-
|
24,95%
|
119,34%
|
Kasstroomconversie (nettowinst)
|
-
|
6,27%
|
-
|
-
|
37,62%
|
175,25%
|
Dividend per aandeel
2 |
0,1000
|
0,1000
|
0,1000
|
0,0800
|
0,1200
|
0,1500
|
Datum van publicatie
|
31/03/18
|
1/04/19
|
7/05/20
|
10/05/21
|
31/03/22
|
1/04/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
-
|
-
|
3,12
|
1,83
|
-
|
-
|
Nettokaspositie
1 |
2,04
|
0,82
|
-
|
-
|
2,86
|
5,6
|
Hefboom (schuld/ebitda)
|
-
|
-
|
0,4541
x
|
0,307
x
|
-
|
-
|
Free Cash Flow
1 |
-0,24
|
0,38
|
-2,23
|
-1,18
|
2,48
|
12,6
|
ROE (netto-inkomsten/eigen vermogen)
|
13,8%
|
11,9%
|
9,66%
|
6,3%
|
9,55%
|
10,8%
|
ROA (netto-inkomsten/totale activa)
|
6,18%
|
5,67%
|
4,94%
|
3,38%
|
6,06%
|
6,45%
|
Totale activa
1 |
99,22
|
108
|
108,3
|
110,3
|
108,8
|
111,2
|
Nettoactief per aandeel
2 |
2,700
|
2,700
|
2,900
|
3,300
|
3,690
|
3,570
|
Cashflow per aandeel
2 |
0,1900
|
0,1400
|
0,0600
|
0,1100
|
0,3000
|
0,4300
|
Capex
1 |
1,7
|
1,39
|
1,57
|
1,46
|
2,19
|
0,68
|
Capex/omzet
|
5,71%
|
4,51%
|
4,6%
|
4,01%
|
4,74%
|
1,48%
|
Datum van publicatie
|
31/03/18
|
1/04/19
|
7/05/20
|
10/05/21
|
31/03/22
|
1/04/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +0,26% | 68,58 mln. | | +19,62% | 43,34 mld. | | +20,44% | 21,96 mld. | | +10,86% | 14,09 mld. | | +13,07% | 13,64 mld. | | +37,46% | 11,43 mld. | | -8,59% | 6,86 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +8,46% | 5,22 mld. |
Generieke geneesmiddelen
|